Strategic Overview

Intelligenome is developing CRISPR-based diagnostic solutions for TB using innovative gene-editing technology for high-quality molecular diagnostics.

Innovation Portfolio

CRISPR-TB
Category: DIAGNOSIS Stage: Commercial

CRISPR-Cas based molecular test for MTBC detection from blood samples. Leverages collateral cleavage activity for sensitive, specific detection with simple readout.

Molecular Blood
Lab-in-A Tube
Category: DIAGNOSIS Stage: Late Stage

Fully integrated molecular test in a single-tube format for MTBC detection from blood. Minimizes contamination risk and simplifies workflow for point-of-care use.

Molecular Blood

Key Milestones

Pioneering CRISPR-based TB diagnostics
Developing point-of-care solutions
Blood-based testing innovation